ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 100 filers reported holding ENDOCYTE INC in Q3 2013. The put-call ratio across all filers is 15.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $11,907,000 | +42.7% | 670,451 | +10.9% | 0.00% | 0.0% |
| Q2 2018 | $8,345,000 | +138.6% | 604,743 | +57.2% | 0.00% | +200.0% |
| Q1 2018 | $3,497,000 | +238.5% | 384,782 | +59.3% | 0.00% | – |
| Q4 2017 | $1,033,000 | +251.4% | 241,498 | +15.6% | 0.00% | – |
| Q3 2017 | $294,000 | -6.1% | 208,895 | 0.0% | 0.00% | – |
| Q2 2017 | $313,000 | -55.5% | 208,895 | -23.7% | 0.00% | – |
| Q1 2017 | $703,000 | +8.3% | 273,757 | +7.5% | 0.00% | – |
| Q4 2016 | $649,000 | -14.5% | 254,619 | +3.6% | 0.00% | – |
| Q3 2016 | $759,000 | -2.6% | 245,865 | +1.3% | 0.00% | – |
| Q2 2016 | $779,000 | +2.4% | 242,815 | -1.2% | 0.00% | – |
| Q1 2016 | $761,000 | -20.8% | 245,677 | +2.5% | 0.00% | -100.0% |
| Q4 2015 | $961,000 | -11.0% | 239,655 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $1,080,000 | -10.6% | 235,981 | +1.3% | 0.00% | 0.0% |
| Q2 2015 | $1,208,000 | -5.1% | 232,939 | +14.5% | 0.00% | 0.0% |
| Q1 2015 | $1,273,000 | +1.4% | 203,459 | +1.9% | 0.00% | 0.0% |
| Q4 2014 | $1,255,000 | +3.5% | 199,652 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $1,212,000 | -6.0% | 199,397 | +1.9% | 0.00% | 0.0% |
| Q2 2014 | $1,290,000 | -69.1% | 195,753 | +11.5% | 0.00% | -66.7% |
| Q1 2014 | $4,181,000 | +131.1% | 175,609 | +3.7% | 0.00% | +200.0% |
| Q4 2013 | $1,809,000 | -6.1% | 169,307 | +17.2% | 0.00% | -50.0% |
| Q3 2013 | $1,926,000 | +4.6% | 144,505 | +3.0% | 0.00% | 0.0% |
| Q2 2013 | $1,842,000 | – | 140,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|